Work

Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz239.017

Authors: B. De Laere, A. Crippa, C. Ghysel, P. Ost, P. Rajan, M. Eklund, L. Dirix, H. Grönberg, J. Lindberg

Institutions: Karolinska Institutet, AZ Sint-Jan, Ghent University Hospital, Queen Mary University of London, Barts Cancer Institute, University of Antwerp, GZA Ziekenhuizen Campus Sint-Augustinus, GZA Ziekenhuizen

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2977620704

FWCI:

Cites:

Cited by: 1

Related to: 10